Chile - hiszpański - ISPC (Instituto de Salud Pública de Chile)

synthon chile ltda. - celecoxib - celecoxib 200,00 mg - tratamiento sintomático de la osteoartritis y de la artritis reumatoide. alivio de los signos y síntomas de la espondilitis anquilosante. manejo del dolor agudo. tratamiento de la dismenorrea primaria.

Chile - hiszpański - ISPC (Instituto de Salud Pública de Chile)

synthon chile ltda. - celecoxib - sin formulas

Izrael - angielski - Ministry of Health

trima israel pharmaceutical products maabarot ltd - celecoxib - capsules - celecoxib 200 mg - celecoxib - celecoxib - symptomatic treatment of inflammation and pain in osteoarthritis (oa) and rheumatoid arthritis (ra).

Izrael - angielski - Ministry of Health

trima israel pharmaceutical products maabarot ltd - celecoxib - capsules - celecoxib 100 mg - celecoxib - celecoxib - symptomatic treatment of inflammation and pain in osteoarthritis (oa) and rheumatoid arthritis (ra).

Belgia - niderlandzki - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - celecoxib 100 mg - capsule, hard - 100 mg - celecoxib 100 mg - celecoxib

Belgia - niderlandzki - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - celecoxib 200 mg - capsule, hard - 200 mg - celecoxib 200 mg - celecoxib

Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios cinfa, s.a. - celecoxib - excipientes: lactosa monohidrato,croscarmelosa sodica,laurilsulfato de sodio,laurilsulfato de sodio,laurilsulfato de sodio - productos antiinflamatorios y antirreumÁticos no esteroideos - coxibs - celecoxib

Holandia - niderlandzki - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

mylan b.v. dieselweg 25 3752 lb bunschoten - celecoxib - capsule, hard - ammonia (e 527) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide zwart (e 172) ; indigokarmijn (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; povidon k 30 (e 1201) ; propyleenglycol (e 1520) ; schellak glaze, gedeeltelijk veresterd ; siliciumdioxide (e 551) ; titaandioxide (e 171) ; zwarte inkt, - celecoxib

Holandia - niderlandzki - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

mylan b.v. dieselweg 25 3752 lb bunschoten - celecoxib - capsule, hard - ammonia (e 527) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; povidon k 30 (e 1201) ; propyleenglycol (e 1520) ; schellak glaze, gedeeltelijk veresterd ; siliciumdioxide (e 551) ; titaandioxide (e 171) ; zwarte inkt, - celecoxib

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

apotex nz ltd - celecoxib 100mg - capsule - 100 mg - active: celecoxib 100mg excipient: crospovidone gelatin magnesium stearate povidone purified water sodium laurilsulfate tekprint blue sb-6018 titanium dioxide - symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. for the management of acute pain and treatment of primary dysmenorrhoea in adults. the decision to prescribe a selective cox-2 inhibitor should only be made: · if non-pharmaceutical interventions and simple analgesic therapies have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient, and · after assessment of the individual patient's overall risks. as the cardiovascular risks of the selective cox-2 inhibitors may increase with dose and duration of exposures, the shortest duration possible and the lowest effective daily dose should be used. patients on long-term treatment should be reviewed regularly, such as every three months, with regards to efficacy, risk factors and ongoing need for treatment